Sankala Group’s Astera Labs ALAB Stock Holding History

Sankala Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.97K	Hold	30	–	–	0.01%	410
2026 Q1	$3.4K	Hold	30	–	–	﹤0.01%	460
2025 Q4	$3.56K	Buy	+30	New	+$5.02K	﹤0.01%	471

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sankala Group's ALAB Position: Q2 2026 in Review

Sankala Group held its Astera Labs (ALAB) position steady in Q2 2026 at 30 shares worth $8.97K. The position accounts for 0.01% of the portfolio, ranked #410.

Sankala Group first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Sankala Group held 30 shares of Astera Labs worth $8.97K as of Q2 2026.
Sankala Group left its Astera Labs share count unchanged in Q2 2026.
Astera Labs made up 0.01% of Sankala Group's portfolio in Q2 2026, its #410 holding.
Sankala Group first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.